Use of methotrexate for leprosy reactions. Experience of a referral center and systematic review of the literature
- 14 April 2020
- journal article
- review article
- Published by Elsevier BV in Travel Medicine and Infectious Disease
- Vol. 37, 101670
- https://doi.org/10.1016/j.tmaid.2020.101670
Abstract
No abstract availableKeywords
Funding Information
- ISCIII (RD16/0027/0020)
- Red de Enfermedades Tropicales
- Subprograma RETICS del Plan Estatal de I (+ D + I 2013–2016)
- FEDER
This publication has 26 references indexed in Scilit:
- A Phase Two Randomised Controlled Double Blind Trial of High Dose Intravenous Methylprednisolone and Oral Prednisolone versus Intravenous Normal Saline and Oral Prednisolone in Individuals with Leprosy Type 1 Reactions and/or Nerve Function ImpairmentPLoS Neglected Tropical Diseases, 2011
- Severe Refractory Erythema Nodosum Leprosum Successfully Treated with the Tumor Necrosis Factor Inhibitor EtanerceptClinical Infectious Diseases, 2011
- Comparative Sequence Analysis ofMycobacterium lepraeand the New Leprosy-CausingMycobacterium lepromatosisJournal of Bacteriology, 2009
- Methotrexate Treatment for Type 1 (Reversal) Leprosy ReactionsClinical Infectious Diseases, 2007
- Treatment of Recurrent Erythema Nodosum Leprosum with InfliximabThe New England Journal of Medicine, 2006
- Development of Leprosy and Type 1 Leprosy Reactions after Treatment with Infliximab: A Report of 2 CasesClinical Infectious Diseases, 2006
- The Continuing Challenges of LeprosyClinical Microbiology Reviews, 2006
- Steroid prophylaxis for prevention of nerve function impairment in leprosy: randomised placebo controlled trial (TRIPOD 1)BMJ, 2004
- LeprosyThe Lancet, 2004
- Incidence of acute nerve function impairment and reactions in leprosy: a prospective cohort analysis after 5 years of follow-upInternational Journal of Epidemiology, 2004